111, Inc. (NASDAQ:YI) Short Interest Up 94.1% in March

111, Inc. (NASDAQ:YI) saw a large growth in short interest in March. As of March 15th, there was short interest totalling 6,600 shares, a growth of 94.1% from the February 28th total of 3,400 shares. Approximately 0.1% of the company’s stock are sold short. Based on an average trading volume of 40,600 shares, the short-interest ratio is currently 0.2 days.

Institutional Investors Weigh In On 111

A number of institutional investors and hedge funds have recently bought and sold shares of YI. JPMorgan Chase & Co. boosted its holdings in shares of 111 by 43,619.9% in the fourth quarter. JPMorgan Chase & Co. now owns 306,039 shares of the company’s stock valued at $191,000 after acquiring an additional 305,339 shares during the period. Napean Trading & Investment Co Singapore PTE Ltd purchased a new stake in 111 in the 4th quarter valued at $245,000. Finally, FIL Ltd purchased a new stake in 111 in the 4th quarter valued at $450,000. 21.32% of the stock is owned by hedge funds and other institutional investors.

111 Stock Down 7.7 %

YI stock opened at $9.05 on Friday. The business has a 50 day moving average price of $7.76 and a 200 day moving average price of $7.43. The stock has a market cap of $77.40 million, a price-to-earnings ratio of -2.26 and a beta of 0.46. 111 has a fifty-two week low of $4.15 and a fifty-two week high of $14.10.

111 (NASDAQ:YI) last released its quarterly earnings data on Thursday, March 20th. The company reported ($0.04) earnings per share for the quarter. The business had revenue of $527.14 million for the quarter.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of 111 in a research note on Saturday, March 22nd.

About 111

111, Inc engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies.